Researchers studied women who carry BRCA1 or BRCA2 gene mutations—genes linked to a higher risk for breast and ovarian cancer. Even though these women had never been diagnosed with cancer, the scientists wanted to see if their blood showed early signs of cellular stress or aging. They looked at something called telomeric cell-free DNA (cfDNA), which comes from the protective caps at the ends of our chromosomes and can be found floating in the bloodstream. Shortened telomeres are linked to aging and cancer, so measuring these DNA fragments might offer clues about underlying health risks.
To do this, the researchers used blood plasma samples from healthy women, including many obtained through the Komen Tissue Bank. This resource gave them access to high-quality samples from women with and without BRCA mutations. The study found that women with the mutations had lower levels of telomeric cfDNA, suggesting that their cells may be aging or breaking down faster—possibly long before any signs of cancer appear. While it was a small pilot study, it points to the potential of a simple blood test to help monitor cancer risk in people with genetic predispositions.
